Northside/Northpoint OB-GYN

Call: (404) 255 3633

Vitamin D doses often don’t match labels, study says

Dr. Bret Lewis found the following article published in USA TODAY very interesting:


Kim Painter, Special for USA TODAY11:44p.m. EST February 11, 2013 Vit D

The potency of vitamin D supplements varies widely, according to new research. (Photo: Sean Dougherty, USA TODAY) Story Highlights

  • Vitamin D pills sold in stores contained 9% to 140% of dose on label
  • Previous studies have found similar results for other supplements
  • Manufacturers’ group says companies are improving

What’s in your vitamin supplement? It could be more or less than you think, according to the latest study to show that what’s on a supplement label is not necessarily what’s in the bottle. Researchers who tested vitamin D pills sold in stores found they contained from 9% to 140% of the doses listed on labels, according to a research letter published Monday in JAMA Internal Medicine. Though none of the pills was likely to be dangerous, some contained too little of the vitamin to effectively treat someone with a deficiency, the researchers say. “We found the potency of these vitamin D supplements varied widely,” says Erin LeBlanc, an endocrinologist who led the study at the Kaiser Permanente Center for Health Research in Portland, Ore. Other studies have found similar variations in other supplements. For example, more than one-third of multivitamins tested by in 2009 were contaminated or contained significantly more or less of some ingredients than their labels claimed. The company also recently tested vitamin D samples and found some mislabeling, it says. About half of adults in the USA take dietary supplements, spending $30 billion a year, according the Office of Dietary Supplements, National Institutes of Health. Vitamin D is particularly popular. The vitamin is essential for bone health and may have other benefits, but most people get enough from food and sun exposure, according to the Institute of Medicine. LeBlanc decided to test over-the-counter vitamin D pills after testing pills made at a compounding pharmacy for another study. She was surprised to find that those specially made pills contained 52% to 146% of the promised vitamin D doses. “I was curious about what else was out there,” LeBlanc says. She and her team went to five “mainstream grocery stories” in Portland, she says, and bought 55 bottles of vitamin D supplements from 12 different manufacturers. Promised potencies ranged from 1,000 to 10,000 international units (IUs). The actual amounts in the pills ranged from 9% to 140% of what was on the label. When researchers tested five pills from each bottle and averaged the results, levels were closer to 100%, but in a third of cases, they were still too high or low by the standards set by one independent testing group, the U.S. Pharmacopeial Convention (USP). The closest match was in the one brand with a USP mark, the researchers say. “It’s not surprising that they found a lot of products that were not meeting label claims,” says John Atwater, director of the verification program at the non-profit USP, one of several groups that offer voluntary testing programs and approval seals. Supplement makers must pay to participate in those programs. Unlike drug companies, supplement makers are not required to prove their products are safe and effective before selling them. The Food and Drug Administration can inspect supplement plants for good manufacturing practices and has issued warnings to many of them under regulations finalized in 2007. But the FDA does not test every product, even at plants under inspection, Atwater says. Companies that put out mislabeled products “are breaking the law,” says Duffy MacKay, vice president of scientific and regulatory affairs for the Council for Responsible Nutrition, a supplement trade association. He says responsible companies are responding to FDA and public pressure to do better. He suggests consumers look for well-known brands and voluntary testing seals. “We’re hoping that soon we’ll have a perfect record,” MacKay say. “We advocate very strongly for 100% compliance.” LeBlanc says her study is evidence that more regulation is needed to get companies in line. TLGX Women’s Health Clinical Update: Vitamin D Deficiency Associated with SGA A recent study associated vitamin D deficiency with higher odds for small-for-gestational age in both black and white infants. Women (1067 white, 236 black) from eight obstetrical offices in Massachusetts participated in the study. Mean 2nd trimester 25(OH)D was 18.4 ng/mL for black and 24.8 ng/mL for white mothers, and mean cord plasma 25(OH)D was 12.4 ng/mL for black and 20.4 ng/mL for white infants. Both maternal 2nd trimester and cord plasma 25(OH)D levels less than 10 ng/mL were associated with a higher odds of SGA. Though SGA was higher among black versus white infants, 2nd trimester 25(OH)D status attenuated the association.

This entry was posted in Annual exams, Attempting Pregnancy, Diet, Food Safety In Pregnancy, High Risk Pregnancies, Low Birth Weight, Osteoporosis, Overall Health, Prenatal care, Preterm Birth, Well Woman Visits and tagged , , , , , , , , . Bookmark the permalink.

Comments are closed.